In February 2025, Gilead settled patent litigation with Apotex and its manufacturer MSN Laboratories regarding cobicistat, a key component in its Genvoya product. This recent legal action underscores the continuous threat to mature product revenue streams from generic drug makers.
Filing excerpt
In February 2025, Gilead reached an agreement with one generic manufacturer (Apotex, Inc., together with Apotex Corp., and its manufacturer of cobicistat, MSN Laboratories Private Limited, MSN Life Sciences Private Ltd., and MSN P
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Competitors named
sec-10klitigationMaterialGet every 10-K signal for Gilead and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Gilead this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/48653ce6-bfb9-4fa9-8341-ce8b64e7deae returns this record as JSON. POST /v1/companies/enrich returns every signal for gilead.com.
{
"signal_id": "48653ce6-bfb9-4fa9-8341-ce8b64e7deae",
"signal_type": "sec-10k",
"signal_subtype": "litigationMaterial",
"detected_at": "2026-03-03T05:50:03.57+00:00",
"company": {
"name": "Gilead",
"domain": "gilead.com"
},
"data": {
"detail": "In February 2025, Gilead settled patent litigation with Apotex and its manufacturer MSN Laboratories regarding cobicistat, a key component in its Genvoya product. This recent legal action underscores the continuous threat to mature product revenue streams from generic drug makers.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Reached patent settlement with Apotex over HIV drug Genvoya in Feb 2025",
"excerpts": "In February 2025, Gilead reached an agreement with one generic manufacturer (Apotex, Inc., together with Apotex Corp., and its manufacturer of cobicistat, MSN Laboratories Private Limited, MSN Life Sciences Private Ltd., and MSN P",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm",
"filing_date": "2026-02-24",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Legal tech opportunity",
"signal_category": "risk",
"competitors_mentioned": [
"Apotex, Inc.",
"Apotex Corp.",
"MSN Laboratories Private Limited",
"MSN Life Sciences Private Ltd."
]
}
}
curl https://signals.autobound.ai/v1/signals/48653ce6-bfb9-4fa9-8341-ce8b64e7deae \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"gilead.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.